1.
Andrographolide suppresses cervical cancer progression by targeting angiogenesis and inducing apoptosis in a CAM-PDX model. Biomol Biomed [Internet]. 2025 Jul. 31 [cited 2025 Aug. 12];25(8):1780–1788. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11432